Global Domperidone Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Domperidone Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Domperidone tablet is a peripheral dopamine receptor blocker, which directly acts on gastrointestinal wall. It can increase the tension of lower esophageal sphincter, prevent gastroesophageal reflux, enhance gastric peristalsis, promote gastric emptying, coordinate gastric and duodenal motility, inhibit nausea and vomiting, and effectively prevent bile reflux without affecting gastric juice secretion. Domperidone tablets can not easily pass the blood-cerebrospinal fluid barrier and inhibit dopamine receptors in the brain. Therefore, there are no neurological and psychiatric adverse reactions such as extrapyramidal system.
Domperidone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Domperidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Domperidone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Domperidone key manufacturers include Schwitz Biotech, Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical, Hunan Qianjin Xiangjiang, Foshan Shouxin Pharmaceutical, Jiangxi Jiezhong Biochemistry, Meenaxy Pharma Pvt. Ltd and Hainan Asia Pharmaceutical, etc. Schwitz Biotech, Luckys Pharma, Shreeji Pharma International are top 3 players and held % sales share in total in 2022.
Domperidone can be divided into Tablets, Pellets and Other,, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Domperidone is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Domperidone industry development. In 2022, global % sales of Domperidone went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Domperidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Schwitz Biotech
Luckys Pharma
Shreeji Pharma International
Xian Janssen Pharmaceutical
Hunan Qianjin Xiangjiang
Foshan Shouxin Pharmaceutical
Jiangxi Jiezhong Biochemistry
Meenaxy Pharma Pvt. Ltd
Hainan Asia Pharmaceutical
Lizhu Pharmaceutical Group
Jiangxi Huiren Pharmaceutical
Segment by Type
Tablets
Pellets
Other
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Domperidone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Domperidone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Domperidone industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Domperidone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Domperidone introduction, etc. Domperidone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Domperidone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Domperidone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Domperidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Domperidone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Domperidone key manufacturers include Schwitz Biotech, Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical, Hunan Qianjin Xiangjiang, Foshan Shouxin Pharmaceutical, Jiangxi Jiezhong Biochemistry, Meenaxy Pharma Pvt. Ltd and Hainan Asia Pharmaceutical, etc. Schwitz Biotech, Luckys Pharma, Shreeji Pharma International are top 3 players and held % sales share in total in 2022.
Domperidone can be divided into Tablets, Pellets and Other,, etc. Tablets is the mainstream product in the market, accounting for % sales share globally in 2022.
Domperidone is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Domperidone industry development. In 2022, global % sales of Domperidone went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Domperidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Schwitz Biotech
Luckys Pharma
Shreeji Pharma International
Xian Janssen Pharmaceutical
Hunan Qianjin Xiangjiang
Foshan Shouxin Pharmaceutical
Jiangxi Jiezhong Biochemistry
Meenaxy Pharma Pvt. Ltd
Hainan Asia Pharmaceutical
Lizhu Pharmaceutical Group
Jiangxi Huiren Pharmaceutical
Segment by Type
Tablets
Pellets
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Domperidone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Domperidone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Domperidone industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Domperidone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Domperidone introduction, etc. Domperidone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Domperidone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.